Fingerprint
Dive into the research topics of 'A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma
Lawrence Liu, Mark Fiala, Feng Gao, Justin King, Scott Goldsmith, Tanya M. Wildes, Keith Stockerl-Goldstein, Ravi Vij, Mark A. Schroeder
Research output: Contribution to journal › Letter › peer-review
1
Scopus
citations